Molecular subtype is determinant on inflammatory status and immunological profile from invasive breast cancer patients.
about
Cytokines as Mediators of Pain-Related Process in Breast CancerThe Interactions of Obesity, Inflammation and Insulin Resistance in Breast CancerA multi-targeted approach to suppress tumor-promoting inflammationImmunoglobulin free light chains are biomarkers of poor prognosis in basal-like breast cancer and are potential targets in tumor-associated inflammationGenomic pathway analysis reveals that EZH2 and HDAC4 represent mutually exclusive epigenetic pathways across human cancersTumor secretion of CCL22 activates intratumoral Treg infiltration and is independent prognostic predictor of breast cancer.Breast cancer in Brazil: epidemiology and treatment challenges.Antitumor activity of a rhenium (I)-diselenoether complex in experimental models of human breast cancerEffects of Selenium Yeast on Oxidative Stress, Growth Inhibition, and Apoptosis in Human Breast Cancer Cells.Baseline blood immunological profiling differentiates between Her2-breast cancer molecular subtypes: implications for immunomediated mechanisms of treatment response.Can Breast Tumors Affect the Oxidative Status of the Surrounding Environment? A Comparative Analysis among Cancerous Breast, Mammary Adjacent Tissue, and PlasmaPretreatment levels of circulating Th1 and Th2 cytokines, and their ratios, are associated with ER-negative and triple negative breast cancers.Overexpression of HER-2/neu protein attenuates the oxidative systemic profile in women diagnosed with breast cancer.The prognostic value of regulatory T cells infiltration in HER2-enriched breast cancer microenvironment.Oxidant stress as a major determinant of platelet activation in invasive breast cancer.
P2860
Q26774863-AF7A0D17-E2E3-4356-9006-BF07CCDA1FB0Q26777775-094AF6DD-BB14-4C60-8269-2D6B5EC6D1C7Q28393278-1D28D7D4-510A-4E4B-9FC2-4390C185CB23Q33917584-7573A66C-8EA9-4D74-A699-A7D51F5D5363Q35002412-A21102AA-03FE-4440-B5A3-D2F797F511DDQ35016950-7D0EA5E8-1236-4784-B575-216C2C0B536AQ35049061-48F98C05-7896-43F9-B938-3B8C2D432305Q35817271-F9B39BB5-B1CD-4BE6-8AF1-C513D75A8C8EQ36064295-88E534F0-39DA-429D-9DD7-EB1AC9AB255AQ36307206-52E1CC3B-3406-4254-9705-2884730F1E16Q36366978-DA763241-F3A6-4245-8B10-234DD3C8DCABQ37551110-EEA8AB54-7A0B-4575-B654-13CDADCFB712Q39061588-C6932604-54B0-4920-A8AD-7F6F558B73CDQ48093934-FCEA7831-9D70-4135-A6BD-76D1DC08CD2EQ51361563-00DC9F78-B933-4060-B8B8-54EA3CF8CF3A
P2860
Molecular subtype is determinant on inflammatory status and immunological profile from invasive breast cancer patients.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Molecular subtype is determina ...... vasive breast cancer patients.
@en
Molecular subtype is determina ...... vasive breast cancer patients.
@nl
type
label
Molecular subtype is determina ...... vasive breast cancer patients.
@en
Molecular subtype is determina ...... vasive breast cancer patients.
@nl
prefLabel
Molecular subtype is determina ...... vasive breast cancer patients.
@en
Molecular subtype is determina ...... vasive breast cancer patients.
@nl
P2093
P2860
P1476
Molecular subtype is determina ...... nvasive breast cancer patients
@en
P2093
A C S A Herrera
A L Cecchini
A N Colado-Simão
F C Campos
R Cecchini
V J Victorino
P2860
P2888
P304
P356
10.1007/S00262-012-1283-8
P577
2012-05-22T00:00:00Z